Publication | Closed Access
Syntheses of Platinum–Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs
11
Citations
12
References
2016
Year
Platinum(II)-sulindac complexes [{η<sup>2</sup> -C<sub>5</sub> H<sub>4</sub> SN(O)}Pt(DMSO){O(C=O)Sulindac}], [{η<sup>2</sup> -C<sub>5</sub> H<sub>4</sub> SN(O)}PtCl{(S=O)Sulindac}], [{η<sup>2</sup> -C<sub>5</sub> H<sub>4</sub> SN(O)}PtCl{(S=O)Sulindac-succinimide}], and [{η<sup>2</sup> -C<sub>5</sub> H<sub>4</sub> SN(O)}PtCl{(S=O)Sulindac-thymidine}] were synthesized that exhibited IC<sub>50</sub> values of 2.9-4.8 μm against human oral cancer cells OECM1. The poly(lactic-co-glycolic acid) (PLGA) encapsulated [{η<sup>2</sup> -C<sub>5</sub> H<sub>4</sub> SN(O)}PtCl{(S=O)Sulindac}] also showed cytotoxic activity although less potent than the pristine species.
| Year | Citations | |
|---|---|---|
Page 1
Page 1